1. Home
  2. MIDD vs RGEN Comparison

MIDD vs RGEN Comparison

Compare MIDD & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Middleby Corporation (The)

MIDD

Middleby Corporation (The)

N/A

Current Price

$109.72

Market Cap

6.1B

Sector

Industrials

ML Signal

N/A

Logo Repligen Corporation

RGEN

Repligen Corporation

N/A

Current Price

$168.00

Market Cap

9.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MIDD
RGEN
Founded
1888
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.1B
9.5B
IPO Year
1995
1995

Fundamental Metrics

Financial Performance
Metric
MIDD
RGEN
Price
$109.72
$168.00
Analyst Decision
Strong Buy
Buy
Analyst Count
8
12
Target Price
$180.13
$167.67
AVG Volume (30 Days)
503.5K
955.5K
Earning Date
05-08-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
286.96
EPS
0.10
0.24
Revenue
$3,201,202,000.00
$141,236,000.00
Revenue This Year
$5.87
$14.30
Revenue Next Year
$3.22
$14.52
P/E Ratio
$1,083.10
$688.25
Revenue Growth
N/A
35.10
52 Week Low
$104.24
$100.99
52 Week High
$180.13
$188.73

Technical Indicators

Market Signals
Indicator
MIDD
RGEN
Relative Strength Index (RSI) 31.22 49.94
Support Level N/A $156.65
Resistance Level $138.84 $167.74
Average True Range (ATR) 2.85 6.17
MACD 0.40 -2.42
Stochastic Oscillator 25.87 23.30

Price Performance

Historical Comparison
MIDD
RGEN

About MIDD Middleby Corporation (The)

The Middleby Corp is engaged in the foodservice industry. The company develops and manufactures a broad line of solutions used in commercial foodservice and food processing. The group showcases its solutions in the Middleby Innovation Kitchens for commercial foodservice and industrial baking and protein Innovation Centers for food processing solutions.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: